![Martin Gleave](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Gleave
Chief Executive Officer at PC-TRiADD
Martin Gleave active positions
Companies | Position | Start | End |
---|---|---|---|
University of British Columbia | Corporate Officer/Principal | - | - |
BC Cancer Agency
![]() BC Cancer Agency Medical/Nursing ServicesHealth Services BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | - | - |
The Vancouver Prostate Centre
![]() The Vancouver Prostate Centre Miscellaneous Commercial ServicesCommercial Services The Vancouver Prostate Centre provides prostate cancer research, treatment, and education services. Its comprehensive, in-house research program ranges from molecular biology to functional genomics, and encompasses active clinical trials, socio-behavioral studies and research into complementary and alternative medicine. The company was founded in 1998 and is headquartered in Vancouver, Canada. | Director/Board Member | - | - |
PC-TRiADD
![]() PC-TRiADD Miscellaneous Commercial ServicesCommercial Services PC-TRiADD is a translational research program. It also offers pharmaceutical and biotech companies, as well as external researchers, integrated translational research services such as drug discovery, preclinical testing, tumour biology and clinical research. The company is headquartered in Vancouver, Canada. | Chief Executive Officer | - | - |
Sustained Therapeutics, Inc.
![]() Sustained Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Sustained Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in an undisclosed location. Sustained Therapeutics is developing a sustained-release drug delivery platform for managing acute and chronic pain. The Canadian company is currently conducting clinical trials for ST-01, their innovative sustained-release form of Lidocaine, for various pain indications. Patients can join their trials to experience the benefits of sustained-release Lidocaine today. The company was founded by Martin E. Gleave. | Director/Board Member | - | - |
Founder | - | - |
Career history of Martin Gleave
Former positions of Martin Gleave
Companies | Position | Start | End |
---|---|---|---|
SIRONA BIOCHEM CORP. | Director/Board Member | 2015-02-19 | 2017-09-12 |
Independent Dir/Board Member | 2015-02-19 | 2017-09-12 | |
OncoGenex Technologies, Inc.
![]() OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Director/Board Member | 2000-04-30 | 2008-08-21 |
Chief Tech/Sci/R&D Officer | 2000-04-30 | 2008-08-21 | |
Founder | 2000-04-30 | 2010-02-28 | |
Canadian Urologic Oncology Group
![]() Canadian Urologic Oncology Group BiotechnologyHealth Technology Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada. | Chairman | - | - |
OncoGenex Pharmaceuticals, Inc.
![]() OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Founder | 1991-09-30 | - |
Training of Martin Gleave
University of British Columbia | Doctorate Degree |
Statistics
International
Canada | 9 |
United States | 2 |
Operational
Director/Board Member | 4 |
Founder | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SIRONA BIOCHEM CORP. | Health Technology |
Private companies | 7 |
---|---|
OncoGenex Technologies, Inc.
![]() OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Health Technology |
OncoGenex Pharmaceuticals, Inc.
![]() OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
BC Cancer Agency
![]() BC Cancer Agency Medical/Nursing ServicesHealth Services BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada. | Health Services |
Canadian Urologic Oncology Group
![]() Canadian Urologic Oncology Group BiotechnologyHealth Technology Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada. | Health Technology |
The Vancouver Prostate Centre
![]() The Vancouver Prostate Centre Miscellaneous Commercial ServicesCommercial Services The Vancouver Prostate Centre provides prostate cancer research, treatment, and education services. Its comprehensive, in-house research program ranges from molecular biology to functional genomics, and encompasses active clinical trials, socio-behavioral studies and research into complementary and alternative medicine. The company was founded in 1998 and is headquartered in Vancouver, Canada. | Commercial Services |
PC-TRiADD
![]() PC-TRiADD Miscellaneous Commercial ServicesCommercial Services PC-TRiADD is a translational research program. It also offers pharmaceutical and biotech companies, as well as external researchers, integrated translational research services such as drug discovery, preclinical testing, tumour biology and clinical research. The company is headquartered in Vancouver, Canada. | Commercial Services |
Sustained Therapeutics, Inc.
![]() Sustained Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Sustained Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in an undisclosed location. Sustained Therapeutics is developing a sustained-release drug delivery platform for managing acute and chronic pain. The Canadian company is currently conducting clinical trials for ST-01, their innovative sustained-release form of Lidocaine, for various pain indications. Patients can join their trials to experience the benefits of sustained-release Lidocaine today. The company was founded by Martin E. Gleave. | Health Technology |
- Stock Market
- Insiders
- Martin Gleave
- Experience